Trials / Conditions / Resectable Pancreatic Ductal Adenocarcinoma

Resectable Pancreatic Ductal Adenocarcinoma

12 registered clinical trials studyying Resectable Pancreatic Ductal Adenocarcinoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment NCT06574620	British Columbia Cancer Agency	N/A
Recruiting	Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy NCT06595160	Emory University	—
Active Not Recruiting	New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancrea NCT04481204	M.D. Anderson Cancer Center	Phase 2
Recruiting	Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreat NCT05518903	Mayo Clinic	Phase 2
Active Not Recruiting	A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer NCT05055323	Thomas Jefferson University	Phase 1
Enrolling By Invitation	Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Str NCT04875325	UMC Utrecht	N/A
Suspended	NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreati NCT04484909	M.D. Anderson Cancer Center	Phase 1
Recruiting	Targeted Pathway Inhibition in Patients With Pancreatic Cancer NCT04005690	OHSU Knight Cancer Institute	EARLY_Phase 1
Completed	Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancrea NCT03970252	Jonsson Comprehensive Cancer Center	EARLY_Phase 1
Unknown	Nalirinox Neo-pancreas RAS Mut ctDNA Study NCT04010552	Fundación de investigación HM	Phase 2
Unknown	The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal NCT02978547	British Columbia Cancer Agency	Phase 2
Completed	A Phase II Study of Neoadjuvant FOLFIRINOX NCT02178709	Indiana University	Phase 2